Seractil forte

Quick links to important sections

Seractil forte

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Seractil forte

Quick Facts

Property Description
Active ingredient Dexibuprofen (S-(+)-enantiomer)
Form Film-coated tablet
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common use Relief of pain, inflammation, and fever
Origin Synthetic (Propionic acid derivative)

What Type of Medicine is Seractil forte and What is its Purpose?

Seractil forte is an orally administered film-coated tablet that belongs to the class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), designed to address the symptoms of pain, inflammation, and fever. The medicine contains the single active ingredient, Dexibuprofen. As part of the NSAID class, its general purpose is to provide a systemic effect by targeting the body's inflammatory response pathways. This compound is used for its analgesic and anti-inflammatory action. This means the medicine is broadly used to help ease discomfort and reduce swelling linked to inflammation, such as those associated with common musculoskeletal aches.

What Makes Dexibuprofen Chemically Unique?

The active ingredient, Dexibuprofen, is a synthetic compound and is chemically the purified S-(+)-enantiomer of ibuprofen, a derivative of propionic acid. Unlike standard ibuprofen, which is a racemic mixture of two molecular isomers, Dexibuprofen is a monosemantic drug. This single-isomer composition, which is a distinctive pharmaceutical feature of the product, ensures that the administered active substance is solely the component responsible for the therapeutic effect. The pharmacological effect is mediated by this S-enantiomer, as the drug utilizes the specific active molecule.

How Does Seractil forte Function at a Basic Level?

Seractil forte functions by systemically interrupting a key physiological process: the production of chemical mediators called prostaglandins. This is achieved through the inhibition of the Cyclooxygenase (COX) enzyme system. By limiting prostaglandin synthesis, the medicine helps to diminish the signals that cause pain sensation, localized swelling, and elevated body temperature, thereby providing a core anti-inflammatory, analgesic, and antipyretic benefit.

Regulatory References

  1. EMA review on Ibuprofen and Dexibuprofen

What side effects are possible with Seractil forte?

Possible Side Effects and Safety Information

The safety profile of Seractil forte (Dexibuprofen), a Nonsteroidal Anti-inflammatory Drug (NSAID), is formally defined by documented adverse reactions and specific regulatory constraints. These characteristics are organized by government health authorities to communicate potential risks.

Adverse reactions are classified by frequency, with Common effects typically involving Gastrointestinal Disorders (such as nausea, vomiting, diarrhea, constipation, dyspepsia, and abdominal pain) and Nervous System Disorders (including headache and dizziness).

Serious adverse reactions explicitly documented in regulatory warnings are a key component of the safety profile. These include the risk of potentially fatal cardiovascular thrombotic events (such as myocardial infarction and stroke) and severe gastrointestinal events (bleeding, ulceration, and perforation). Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome (SJS), are also officially listed as possible, though rare.

Safety notes tied to exposure confirm that the risk of serious cardiovascular and gastrointestinal events is officially stated to increase with longer duration of use and at higher doses.

Population-specific safety considerations are noted in the official labeling. Elderly patients are documented as having an increased frequency and greater risk for adverse reactions, particularly serious GI bleeding. Furthermore, the medicine is contraindicated during the third trimester of pregnancy due to fetal risk, and caution is noted for females planning conception due to potential reversible impairment of fertility.

Regulatory safety limitations include the statement that NSAIDs may mask the signs of infection, such as fever. The medicine is contraindicated in patients with a history of recurrent GI ulcers/bleeding, severe heart failure, or previous hypersensitivity to NSAIDs.

Overdose and Emergency Response

Overdose and When to Seek Help

The following information on Dexibuprofen (Seractil forte) overdose is derived exclusively from authoritative government regulatory sources, detailing documented clinical manifestations and mandated emergency actions.


Overdose Scope

Domain Official Regulatory Statements
Documented Overdose Presentations Overdose may initially present with gastrointestinal effects such as nausea, vomiting, and epigastric pain. CNS manifestations listed in official labels include headache, lethargy, drowsiness, and tinnitus.
Physiological Systems Affected (as stated in label) Severe overdose can compromise the Central Nervous System (leading to convulsions or loss of consciousness), the Cardiovascular system, and may lead to Acute Renal Failure and liver damage.
Dose-related or Exposure-related Factors (if applicable) Immediate actions, such as gastric decontamination, are time-sensitive and are typically considered when a potentially toxic dose is ingested within one hour.
Population-specific Overdose Notes (if applicable) Regulatory information specifies that elderly patients may face an increased risk of severe gastrointestinal complications.
Emergency-response statements (as written in official documents) Management is defined as symptomatic and supportive. No specific antidote is known. Procedures include the potential use of activated charcoal and the administration of intravenous benzodiazepines for seizures.
When immediate medical help is required (label-derived phrasing only) Seek immediate medical attention. Contact emergency services immediately. Hospital monitoring is required for assessment of vital signs, and hepatic and renal function.

Overdose Classifications (High-Level)

Domain Official Regulatory Statements
Severity classification (as defined in official documents) Effects range from mild, self-limiting symptoms to severe or life-threatening outcomes, including metabolic acidosis and respiratory depression.
Regulatory basis (EMA / FDA / etc.) Based on official overdose sections of regulatory documents, including EMA Summary of Product Characteristics (SmPC) and FDA Prescribing Information.
Overdose-context constraints (as defined in official documents) The absence of a specific antidote necessitates a strictly supportive and symptomatic approach to management.

Resulting Overdose Structure

Official overdose statements:

  • Immediate action is required: Regulatory instructions mandate that immediate medical attention must be sought and emergency services contacted.
  • Severe organ risk: Overdose is officially associated with the potential for acute renal failure and liver damage.
  • Management is symptomatic: The regulatory procedure is limited to symptomatic and supportive treatment as no specific antidote is known.

Connection to the overall overdose profile:

Governmental regulatory documents define the overdose profile by listing specific clinical manifestations, such as dizziness and epigastric pain, alongside severe risks like hypotension and convulsions. This documented risk dictates the non-negotiable instruction to seek immediate medical attention and requires hospital monitoring of organ function, as management relies entirely on supportive care.

Therapeutic Uses of Seractil forte

What Seractil forte Treats: Main Uses and Benefits

Seractil forte (Dexibuprofen) is a medicine used to provide symptomatic relief by addressing the core cluster of pain, inflammation, and fever in various clinical contexts. It contributes to easing the overall symptom load.

The medication is commonly used across domains where additional symptomatic support is needed in conditions like osteoarthritis and for the short-term management of symptoms related to rheumatoid arthritis. It is also relevant for easing symptoms associated with primary dysmenorrhoea (menstrual pain), headache, dental pain, and pain following minor soft tissue injuries.

Managing Musculoskeletal Pain and Inflammatory Conditions

This domain addresses symptoms related to inflammatory or irritative states that create noticeable physiological strain, particularly those involving the body's tissues, joints, and muscles. Seractil forte is applicable for conditions where it is relevant for easing discomfort and swelling, often used to help manage pain and swelling that follow a minor injury or are part of general musculoskeletal aches.

Relief for Acute Pain, Dysmenorrhoea, and Fever

Seractil forte is relevant when supportive symptom management is appropriate for symptoms associated with acute or episodic changes. It is commonly used to help with symptom clusters that may become intense or disruptive, such as mild to moderate pain from conditions like headache or dental pain. Furthermore, it is applied in addressing symptoms related to systemic imbalance, such as fever associated with cold or flu episodes. This contributes to improved comfort during periods of heightened symptoms.

Quick Fact: Symptomatic Scope Description
Therapeutic Scope Symptomatic relief of pain, inflammation, and fever
Pain Severity Mild to moderate
Episodic Use Primary dysmenorrhoea (menstrual pain)
Key Benefit Supports comfort during heightened symptomatic periods

Regulatory References

  1. Read more from the European Medicines Agency therapeutic overview

Eligibility and Restrictions for Use

Who can and cannot use Seractil forte?

Eligibility for Seractil forte (Dexibuprofen) is strictly defined by government regulatory documents, focusing on pre-existing conditions and population status.


Absolute Contraindications (Must Not Use)

The medicine is contraindicated for patients with a history of hypersensitivity to NSAIDs, and those with active gastrointestinal ulceration or bleeding, severe heart failure, severe renal dysfunction, or severely impaired hepatic function. Use is strictly prohibited in the last trimester of pregnancy.


Population Restrictions and Conditional Use

Population Group Regulatory Status Restriction Details
Pediatrics (<18 years) Not recommended Safety and efficacy have not been established in this age group.
Pregnancy Contraindicated Prohibited in the third trimester (after 30 weeks gestation).
Cardiovascular Risk Conditional use High doses must be avoided in patients with established cardiovascular disease.
Organ Impairment Conditional use Patients with mild to moderate renal or hepatic impairment require close monitoring and dose reduction.

Eligible Populations

Seractil forte is intended for use by adults under standard labeled conditions, provided they have no contraindications. Eligibility for children and adolescents from 8 years of age is acknowledged for specific symptomatic uses in some regions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Seractil forte (Dexibuprofen) details specific combinations that may result in altered drug exposure or increased pharmacodynamic risk, as documented in official regulatory prescribing information. The co-administration of certain substances is explicitly restricted or classified as contraindicated due to these documented effects.

Pharmacodynamic Interactions and Restrictions

Classification Interacting Entity Official Outcome Statement
Contraindicated/Avoided Other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Co-administration must be avoided due to a documented increased risk of gastrointestinal ulceration or bleeding.
Reduced Efficacy Antihypertensives, Diuretics The therapeutic effect of these medicines may be reduced.
Additive Risk Anticoagulants, Corticosteroids, SSRIs Significantly enhances the effect of anticoagulants and increases the risk of bleeding complications.
Competitive Effect Low-dose Acetylsalicylic Acid (ASA) May reduce the cardioprotective anti-platelet effect of ASA.

Pharmacokinetic and Substance Interactions

Interactions involving the alteration of drug exposure include those that reduce renal clearance, leading to increased plasma concentrations of medicines such as Lithium and Methotrexate. The concurrent ingestion of alcohol is documented as increasing the risk of gastric irritation and gastrointestinal mucosal bleeding.

Mechanism of Action

The mechanism involves the interaction of the molecule with defined biological targets that modulate key physiological signaling pathways. The action involves the inhibition of enzymes that catalyze the synthesis of eicosanoids, which act as local mediators.

Target: Competitive Blockade of Cyclooxygenase Enzymes

The drug initiates its mechanism by acting as a reversible, competitive inhibitor of the Cyclooxygenase (COX) enzyme system, affecting both the COX-1 and COX-2 isoforms. This action blocks the initial molecular step in the Arachidonic Acid Cascade, which is required for the synthesis of eicosanoids.

Pathway: Suppression of Prostaglandin Synthesis

The enzymatic blockade results in a systemic decrease in the synthesis of various prostaglandins, particularly PGE2. The resulting reduction in PGE2 modulates the excitation threshold of peripheral nociceptors and lowers the elevated set point in the hypothalamic thermoregulatory center.

Consequence: Targeted Physiological Adjustment

As the active ingredient is the purified S-(+)-enantiomer (Dexibuprofen), the mechanism involves the pharmacologically active molecular configuration binding to the biological target. This molecular interaction engages the targeted pathway, leading to physiological adjustments that are consistent with the inhibition of eicosanoid synthesis.

Dosage and Administration Information

How Seractil forte is Used

Seractil forte (Dexibuprofen) is administered orally in the form of a film-coated tablet, using a divided-dose schedule to manage symptomatic relief. The usage protocol is designed to achieve the lowest effective therapeutic level while minimizing the duration of exposure.

Administration Protocol

The tablets should be swallowed with water. To minimize potential gastrointestinal discomfort, it is advised to take the medicine with food or immediately after a meal. The 400 mg strength tablet is scored and can be divided into two equal doses when required by the prescribing regimen. If a dose is missed, it is specified that a double dose must not be taken to compensate.


Official Dosing Regimen

The dosage is standardized to achieve symptom control and is typically based on the following framework:

Feature Labeled Instruction
Dosing Frequency Administered in divided doses, generally two to three times per day.
Dose Interval A minimum of six hours must be maintained between doses.
Daily Maximum The maximum recommended daily intake for an adult is 1200 mg.
Duration Principle Used for the shortest duration necessary to control symptoms.

Population-Specific Adjustments

Dose modification is applied for certain patient populations. For older adults (65+), treatment should begin at a reduced initial daily dose. Similarly, the initial dose must be lowered and closely monitored for patients with established mild to moderate renal or hepatic impairment.

Recent Clinical Evidence

Research evidence / Overview of studies


Compound Characteristics: How it was studied

Research studies investigated a compound that is thought to influence inflammatory pathways. Research has explored whether the compound could influence pain and function in individuals with moderate to severe osteoarthritis and other inflammatory conditions.

Clinical Studies: What was evaluated

Overall, studies have evaluated the use of this treatment in several thousand participants across different study designs, including double-blind, placebo-controlled trials. The research focused primarily on patients with established inflammatory conditions.

  • Short-Term Evaluation: Trials evaluated the effects over 4 to 12 weeks. One phase III study, involving 600 participants, examined the speed of any reported relief and relief was evaluated compared to placebo using scales like the WOMAC pain scale.
  • Long-Term Use: The compound was also evaluated for long-term use, with some follow-up periods lasting up to one year, primarily exploring the duration of any changes in symptom severity.
  • Combination Therapy: Research has explored whether a combination with a standard disease-modifying agent has added benefits. The combination was examined for its potential influence on joint mobility and quality of life measures.

Tolerability Profile: Research Findings

Tolerability data was collected consistently across all major trials, with specific attention given to potential effects on major organ systems.

  • Cardiovascular Risks: Research has explored whether an increased risk of cardiovascular events, such as myocardial infarction, was observed in the group receiving the study medication compared to the placebo group. The findings were mixed across different studies, reflecting findings for the NSAID class generally.
  • Renal Function: Studies evaluated the medication in people with pre-existing kidney conditions to monitor for changes in renal markers. Studies have included elderly patients in their safety analysis to assess the tolerability profile in this group.

Key Studies & References

  1. Cardiovascular safety of non-steroidal anti-inflammatory drugs: a large-scale observational study
  2. NICE Guideline: Osteoarthritis: care and management (NG223)

Frequently Asked Questions (FAQ)

Common questions about Seractil forte (FAQ)

Q: Is Seractil forte used for muscle pain or only joint pain?

A: According to official product information, Seractil forte is indicated for the relief of mild to moderate pain. This generally includes musculoskeletal pain, covering both muscle pain and joint pain that is linked to inflammation.


Q: How quickly does Seractil forte typically start working?

A: Regulatory documents mention that when Seractil forte is taken with food, its absorption may be slower. This means the onset of relief may be delayed compared to taking it without food, especially when seeking quick relief for acute pain.


Q: What is the expected length of time Seractil forte stays active in the body?

A: The official pharmacokinetic data describes how the medicine is processed by the body. Studies indicate that the concentration of the active ingredient typically reaches its highest level in the bloodstream between two and five hours after you take a dose.


Q: Can Seractil forte be taken by people with a sensitive stomach?

A: Official information advises taking the medicine with food or immediately after a meal to help minimize potential stomach irritation or gastrointestinal discomfort. However, this medicine is strictly contraindicated (must not be used) if a patient has an active gastrointestinal ulcer or bleeding.


Q: Is Seractil forte known to cause drowsiness?

A: Official regulatory information classifies dizziness and headache as common side effects related to the nervous system. Drowsiness or feelings of tiredness are also noted in official documents as potential, less common effects.


Q: Are there any common foods or drinks that should be avoided when using Seractil forte?

A: Official documents specifically warn that consuming alcohol while using Seractil forte may increase the risk of side effects, particularly stomach irritation and gastrointestinal bleeding. No specific common foods are mentioned as being restricted.


Q: Can older adults generally use Seractil forte?

A: Older adults can generally use this medicine, but specific regulatory warnings apply. Regulatory information specifies that treatment for older adults often involves a reduced initial dose and requires close monitoring, as official documents indicate these patients have a higher risk of experiencing adverse reactions, especially serious gastrointestinal bleeding.


Q: Is Seractil forte safe to use for a long period of time?

A: Official guidance emphasizes that the lowest effective dose and shortest duration necessary are regulatory principles for use. Regulatory safety notes indicate that the risk of serious side effects, including cardiovascular and gastrointestinal events, increases with higher doses and prolonged use.


Q: Does taking Seractil forte affect blood pressure readings?

A: Official interaction profiles note that Seractil forte may reduce the intended therapeutic effect of certain medicines used to lower blood pressure. Regulatory documents recommend that the blood pressure of patients with existing high blood pressure is monitored closely during treatment.


Q: Can Seractil forte be used for common headaches or migraines?

A: Official regulatory indications for Seractil forte include the relief of mild to moderate pain. This is generally understood to cover common headaches. Use for migraines is not explicitly defined, but the overall indication is for pain relief.


Q: Are there research studies showing Seractil forte's effect on chronic pain?

A: Clinical studies have evaluated the activity of this compound in patients with conditions that involve persistent discomfort, such as osteoarthritis. Research included both short-term evaluation and follow-up periods for up to one year to analyze changes in patient status during long-term use.


Q: Is it normal to feel a mild burning sensation after taking the tablet?

A: Common adverse reactions are known to affect the gastrointestinal system, which include abdominal pain and dyspepsia, or indigestion. These effects can sometimes be experienced as general discomfort or irritation in the stomach region.


Q: Can people with a history of asthma generally use Seractil forte?

A: Official documents state that Seractil forte is strictly contraindicated if you have a history where aspirin or other NSAIDs have triggered attacks of asthma or bronchospasm (sudden difficulty breathing). The official safety information notes that caution is necessary for patients with existing asthma or chronic respiratory issues.


Q: Is it okay to take Seractil forte if I'm taking anti-anxiety medication?

A: Official interaction profiles specifically note an enhanced risk of bleeding when Seractil forte is taken alongside Selective Serotonin Reuptake Inhibitors (SSRIs), which are commonly used for anxiety and depression. Due to the variety of drug classes that constitute 'anti-anxiety medication,' the specific class of medicine must be considered in relation to the interaction profile.


Q: Are there any specific activities or machinery one should avoid while using Seractil forte?

A: Official regulatory guidelines indicate that caution is necessary regarding the operation of machinery or driving. The official patient information states that engaging in these activities should be avoided if side effects such as dizziness, tiredness, or vision disturbances occur.


Q: What is the main reason Seractil forte might be stopped by a doctor?

A: Official regulatory warnings identify the occurrence of a severe hypersensitivity reaction (allergic reaction) or signs of gastrointestinal bleeding or ulceration as conditions that necessitate immediate treatment discontinuation. These conditions are considered serious adverse events.


Q: Does Seractil forte have a risk of becoming habit-forming?

A: Seractil forte belongs to the class of Nonsteroidal Anti-inflammatory Drugs (NSAIDs). The official regulatory safety information for this compound does not list a risk of dependency or becoming habit-forming.


Q: Does Seractil forte affect laboratory blood tests?

A: Regulatory documents note that in some patients, the medicine may cause small, temporary increases in certain liver function test results. For patients with pre-existing kidney concerns, official safety information states that monitoring of renal markers (kidney function indicators) may be required during treatment.


Q: Does Seractil forte interact with common cold or flu medications?

A: Official interaction warnings state that co-administration of Seractil forte with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs) or other pain relievers should be avoided. Since many over-the-counter cold and flu preparations contain these substances, combining them may increase the risk of serious side effects.


Q: What does 'contraindication' mean in the context of Seractil forte?

A: A contraindication is a medical term used in official documents to identify a condition or circumstance where the medicine should not be used. Regulatory bodies strictly define these situations because the potential for harm to the patient is judged to be unacceptably high.


Q: Can Seractil forte generally be used by individuals who are vegan or vegetarian?

A: Official product information, such as the Summary of Product Characteristics (SmPC), includes a comprehensive list of all inactive ingredients (excipients) that may be reviewed to determine alignment with specific dietary restrictions.


Q: How is Seractil forte typically eliminated from the body?

A: Studies regarding how the body processes the medicine (pharmacokinetics) indicate that the active ingredient, dexibuprofen, is predominantly eliminated from the body. The primary pathway for this elimination is renal excretion, which means it is passed out through the kidneys.


Q: Does Seractil forte contain gluten or lactose?

A: Official documents list all inactive ingredients (excipients) that may be reviewed to determine the presence or absence of substances like gluten or lactose for patients with allergies or intolerances.


Q: Is it necessary to drink a full glass of water when taking Seractil forte?

A: Official administration instructions state that the film-coated tablet must be swallowed with water. Taking the medicine with a drink of water is standard procedure for oral tablets and helps to ensure the tablet passes correctly into the stomach.


Q: Can Seractil forte be crushed or split?

A: The 400 mg tablet is manufactured with a score line, which means it is designed and approved to be divided into two equal doses if required by the prescribing regimen. However, the official regulatory information does not provide specific instructions or approval for crushing the film-coated tablet.

How should Seractil forte be stored and disposed of?

The official regulatory requirements for storing and disposing of Seractil forte (400 mg dexibuprofen film-coated tablets) focus on temperature control, child safety, and environmental protection.

Official Storage and Handling

Requirement Constraint
Storage Temperature Do not store above 25 C to maintain product stability.
Child Safety Must be kept out of the sight and reach of children.
Packaging Product is supplied in PVC/ PVDC/ aluminium blisters; observe the 3-year labeled shelf-life.

Disposal Instructions

Official labeling strictly requires that the medicine must not be thrown away via wastewater or household waste. Users are directed to ask a pharmacist for guidance on how to properly dispose of any unused or expired tablets. This is the mandated environmental protection instruction to prevent contamination and ensure disposal aligns with local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Seractil forte found in:

A-Z Index: